Robert Paridaens
Impact in
- Cancer Research top 0.5%
- Breast Cancer Treatment Studies
- Oncology top 0.2%
- HER2/EGFR in Cancer Research
- Cancer Treatment and Pharmacology
- Cancer Risks and Factors
- Bone health and treatments
Papers in
-
- Breast Cancer Treatment Studies 69
- Oncology 124
- Cancer Treatment and Pharmacology 54
- HER2/EGFR in Cancer Research 38
- Cancer Risks and Factors 18
- Neutropenia and Cancer Infections 11
- Co-authors
- Hans P. M. W. Wildiers (60 shared papers)Patrick Neven (67 shared papers)Martine J Piccart (28 shared papers)Marie-Rose Christiaens (28 shared papers)Luc Yves Dirix (14 shared papers)Beat J. K. Thurlimann (12 shared papers)Ignace B. Vergote (35 shared papers)Laura Biganzoli (11 shared papers)
- Journals
- European Journal of Cancer (37 papers)Annals of Oncology (32 papers)Journal of Clinical Oncology (28 papers)Breast Cancer Research and Treatment (24 papers)Current Opinion in Oncology (6 papers)
- Partner nations
- BelgiumUnited KingdomUnited States
In The Last Decade
Robert Paridaens
288 papers receiving 14.5k citations
Robert Paridaens's Hit Papers
Peers
Comparison fields: 5 of 198
- Cancer Research 4.2k
- Oncology 6.5k
- Genetics 4.4k
- Pulmonary and Respiratory Medicine 2.0k
- Family Practice 98
Countries citing papers authored by Robert Paridaens
This map shows the geographic impact of Robert Paridaens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Paridaens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Paridaens more than expected).
Fields of papers citing papers by Robert Paridaens
This network shows the impact of papers produced by Robert Paridaens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Paridaens. The network helps show where Robert Paridaens may publish in the future.
Co-authors
The 25 scholars most cited alongside Robert Paridaens, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 295 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | A Randomized Trial of Exemestane after Two to Three Years of Tamoxifen Therapy in Postmenopausal Women with Primary Breast Cancer Hit paper breakdown → | 2004 | 1464 |
| 2 | Large-scale genotyping identifies 41 new loci associated with breast cancer risk Hit paper breakdown → | 2013 | 908 |
| 3 | Five Years of Letrozole Compared With Tamoxifen As Initial Adjuvant Therapy for Postmenopausal Women With Endocrine-Responsive Early Breast Cancer: Update of Study BIG 1-98 Hit paper breakdown → | 2007 | 746 |
| 4 | Survival and safety of exemestane versus tamoxifen after 2–3 years' tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trial Hit paper breakdown → | 2007 | 716 |
| 5 | MicroRNA Related Polymorphisms and Breast Cancer Risk Hit paper breakdown → | 2014 | 610 |
| 6 | Associations of Breast Cancer Risk Factors With Tumor Subtypes: A Pooled Analysis From the Breast Cancer Association Consortium Studies Hit paper breakdown → | 2010 | 575 |
| 7 | 2010 | 434 | |
| 8 | 2000 | 306 | |
| 9 | 2011 | 302 | |
| 10 | 2008 | 291 | |
| 11 | 2008 | 263 | |
| 12 | 1986 | 225 | |
| 13 | 2003 | 192 | |
| 14 | 2008 | 182 | |
| 15 | 2010 | 182 | |
| 16 | 2008 | 160 | |
| 17 | 2004 | 154 | |
| 18 | 2009 | 151 | |
| 19 | 2005 | 150 | |
| 20 | 2000 | 146 |
About Robert Paridaens
Robert Paridaens is a scholar working on Cancer Research, Oncology, Genetics, Pulmonary and Respiratory Medicine and Reproductive Medicine, having authored 295 papers that have together received 15.2k indexed citations. Recurring topics across this work include Estrogen and related hormone effects (81 papers), Breast Cancer Treatment Studies (69 papers), Cancer Treatment and Pharmacology (54 papers), HER2/EGFR in Cancer Research (38 papers), Cancer Risks and Factors (18 papers), Advanced Breast Cancer Therapies (16 papers), Neutropenia and Cancer Infections (11 papers) and Chemotherapy-induced cardiotoxicity and mitigation (10 papers). The work is most often cited by research in Cancer Research (4.2k citations), Oncology (6.5k citations), Genetics (4.4k citations), Pulmonary and Respiratory Medicine (2.0k citations) and Family Practice (98 citations). Robert Paridaens has collaborated with scholars based in Belgium, United Kingdom and United States. Frequent co-authors include Hans P. M. W. Wildiers, Patrick Neven, Martine J Piccart, Marie-Rose Christiaens, Luc Yves Dirix, Beat J. K. Thurlimann, Ignace B. Vergote, Laura Biganzoli, Aron Goldhirsch and Richard D. Gelber. Their work appears in journals such as European Journal of Cancer, Annals of Oncology, Journal of Clinical Oncology, Breast Cancer Research and Treatment and Current Opinion in Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.